A Three-Year Study of Brain Atrophy after Autologous Hematopoietic Stem Cell Transplantation in Rapidly Evolving Secondary Progressive Multiple Sclerosis

References

1. ↵
   Blanco Y, Saiz A, Carreras E, et al. Autologous haematopoietic stem-cell transplantation for multiple sclerosis. Lancet Neurol 2005;4:54–63

   CrossRefPubMedWeb of Science
2. ↵
   Mancardi GL, Saccardi R, Filippi M, et al. Autologous hematopoietic stem cell transplantation suppresses gadolinium-enhanced MRI activity in multiple sclerosis. Neurology 2001;57:62–68

   Abstract/FREE Full Text
3. ↵
   Samijn JPA, Te Boekhorst PAW, Mondria T, et al. Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis. J Neurol Neurosurg Psychiatry 2006;77:46–50

   Abstract/FREE Full Text
4. ↵
   Chen JT, Collins DL, Atkins HL, et al. Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis. Neurology 2006;66:1935–37

   Abstract/FREE Full Text
5. ↵
   Inglese M, Mancardi GL, Pagani E, et al. Brain tissue loss occurs after suppression of transplantation treated with autologous haematopoietic stem cell enhancement in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2004;75:643–44

   Abstract/FREE Full Text
6. ↵
   Fisher E, Rudick RA, Simon JH, et al. Eight-year follow-up study of brain atrophy in patients with MS. Neurology 2002;59:1412–20

   Abstract/FREE Full Text
7. ↵
   Burt RK, Cohen B, Rose J, et al. Hematopoietic stem cell transplantation for multiple sclerosis. Arch Neurol 2005;62:860–64

   CrossRefPubMedWeb of Science
8. ↵
   Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust and automated longitudinal and cross-sectional brain change analysis. NeuroImage 2002;17:479–89

   CrossRefPubMedWeb of Science
9. ↵
   Inglese M, Benedetti B, Filippi M. The relation between MRI measures of inflammation and neurodegeneration in multiple sclerosis. J Neurol Sci 2005;233:15–19

   CrossRefPubMedWeb of Science
10. ↵
    Miller DH, Barkhof F, Frank JA, et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002;125:1676–95

    Abstract/FREE Full Text
11. ↵
    Saiz A, Blanco Y, Carreras E, et al. Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS. Neurology 2004;62:282–84

    Abstract/FREE Full Text
12. ↵
    Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278–85

    CrossRefPubMedWeb of Science
13. ↵
    Kutzelnigg A, Lucchinetti CF, Stadelman C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005;128:2705–12

    Abstract/FREE Full Text
14. ↵
    Narayana PA. Magnetic resonance spectroscopy in the monitoring of multiple sclerosis [review]. J Neuroimaging 2005;15:46S–57S

    CrossRefPubMedWeb of Science
15. ↵
    Jager HR, Williams EJ, Savage DG, et al. Assessment of brain changes with registered MR before and after bone marrow transplantation for chronic myeloid leukemia. AJNR Am J Neuroradiol 1996;17:1275–82

    Abstract
16. ↵
    Peper M, Steinvorth S, Schraube P, et al. Neurobehavioral toxicity of total body irradiation: a follow-up in long-term survivors. Int J Radiat Oncol Biol Phys 2000;46:303–11

    CrossRefPubMedWeb of Science